UBS Group’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.4M | Sell |
1,435,415
-280,363
| -16% | -$2.63M | ﹤0.01% | 2194 |
|
|
2025
Q1 | $21.1M | Buy |
1,715,778
+686,957
| +67% | +$8.44M | ﹤0.01% | 1739 |
|
|
2024
Q4 | $13.6M | Buy |
1,028,821
+882,383
| +603% | +$11.7M | ﹤0.01% | 2085 |
|
|
2024
Q3 | $2.82M | Buy |
146,438
+21,286
| +17% | +$410K | ﹤0.01% | 2765 |
|
|
2024
Q2 | $2.57M | Sell |
125,152
-144,659
| -54% | -$2.97M | ﹤0.01% | 2632 |
|
|
2024
Q1 | $6.42M | Sell |
269,811
-20,990
| -7% | -$500K | ﹤0.01% | 1966 |
|
|
2023
Q4 | $6.28M | Buy |
290,801
+215,444
| +286% | +$4.66M | ﹤0.01% | 1801 |
|
|
2023
Q3 | $1.09M | Sell |
75,357
-37,359
| -33% | -$542K | ﹤0.01% | 3006 |
|
|
2023
Q2 | $2.36M | Buy |
112,716
+4,401
| +4% | +$92.1K | ﹤0.01% | 2556 |
|
|
2023
Q1 | $2.29M | Sell |
108,315
-64,470
| -37% | -$1.36M | ﹤0.01% | 2467 |
|
|
2022
Q4 | $4.4M | Sell |
172,785
-112,747
| -39% | -$2.87M | ﹤0.01% | 1940 |
|
|
2022
Q3 | $6.86M | Sell |
285,532
-31,143
| -10% | -$748K | ﹤0.01% | 1508 |
|
|
2022
Q2 | $6.09M | Buy |
316,675
+101,511
| +47% | +$1.95M | ﹤0.01% | 1646 |
|
|
2022
Q1 | $3.74M | Buy |
215,164
+74,647
| +53% | +$1.3M | ﹤0.01% | 2162 |
|
|
2021
Q4 | $3.08M | Buy |
140,517
+70,004
| +99% | +$1.53M | ﹤0.01% | 2520 |
|
|
2021
Q3 | $1.35M | Buy |
70,513
+52,141
| +284% | +$996K | ﹤0.01% | 3032 |
|
|
2021
Q2 | $315K | Sell |
18,372
-45,000
| -71% | -$772K | ﹤0.01% | 4047 |
|
|
2021
Q1 | $1.42M | Buy |
63,372
+51,708
| +443% | +$1.16M | ﹤0.01% | 3050 |
|
|
2020
Q4 | $260K | Buy |
11,664
+10,664
| +1,066% | +$238K | ﹤0.01% | 4116 |
|
|
2020
Q3 | $15K | Sell |
1,000
-29,063
| -97% | -$436K | ﹤0.01% | 5659 |
|
|
2020
Q2 | $446K | Buy |
30,063
+14,186
| +89% | +$210K | ﹤0.01% | 3480 |
|
|
2020
Q1 | $174K | Sell |
15,877
-9,918
| -38% | -$109K | ﹤0.01% | 3995 |
|
|
2019
Q4 | $227K | Buy |
25,795
+3,990
| +18% | +$35.1K | ﹤0.01% | 4525 |
|
|
2019
Q3 | $163K | Buy |
21,805
+16,136
| +285% | +$121K | ﹤0.01% | 4514 |
|
|
2019
Q2 | $53K | Buy |
5,669
+3,669
| +183% | +$34.3K | ﹤0.01% | 5018 |
|
|
2019
Q1 | $11K | Sell |
2,000
-8,469
| -81% | -$46.6K | ﹤0.01% | 5920 |
|
|
2018
Q4 | $47K | Buy |
10,469
+7,323
| +233% | +$32.9K | ﹤0.01% | 5244 |
|
|
2018
Q3 | $25K | Buy |
3,146
+1,146
| +57% | +$9.11K | ﹤0.01% | 5761 |
|
|
2018
Q2 | $14K | Sell |
2,000
-1,371
| -41% | -$9.6K | ﹤0.01% | 6027 |
|
|
2018
Q1 | $48K | Buy |
3,371
+1,371
| +69% | +$19.5K | ﹤0.01% | 4895 |
|
|
2017
Q4 | $18K | Sell |
2,000
-362
| -15% | -$3.26K | ﹤0.01% | 5666 |
|
|
2017
Q3 | $27K | Buy |
2,362
+1,821
| +337% | +$20.8K | ﹤0.01% | 5348 |
|
|
2017
Q2 | $8K | Sell |
541
-932
| -63% | -$13.8K | ﹤0.01% | 5974 |
|
|
2017
Q1 | $20K | Buy |
1,473
+665
| +82% | +$9.03K | ﹤0.01% | 5230 |
|
|
2016
Q4 | $6K | Sell |
808
-8,189
| -91% | -$60.8K | ﹤0.01% | 6190 |
|
|
2016
Q3 | $136K | Buy |
8,997
+8,126
| +933% | +$123K | ﹤0.01% | 3971 |
|
|
2016
Q2 | $9K | Buy |
+871
| New | +$9K | ﹤0.01% | 5951 |
|